Trial ID
SGN-PDL1V
Sponsor ID
SGNPDL1V-001
A Phase 1 Study of SGN-PDL1V in Advanced Solid Tumors
Principal Investigator
Alexander I. Spira, MD, PhD, FACPLocations
Fairfax Office
Learn More About This Trial
Other Relevant Trials
Trial ID
TAK-981-1502
Sponsor ID
Takeda Oncology
Phase 1b/2 Study of TAK-981 Plus Pembrolizumab to Evaluate the Safety, Tolerability, and Antitumor Activity of the Combination in Patients With Select Advanced or Metastatic Solid Tumors
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
Trial ID
M20-111
Sponsor ID
AbbVie
“A Phase 1 first in human study evaluating safety and efficacy of ABBV-637 as either monotherapy or in combination in adult subjects with relapsed and refractory solid tumors”
Principal Investigator
Alexander I. Spira, MD, PhD, FACP
1 Location
